Trine Bertelsen
Aalborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
"Local injection of freshly collected autologous adipose tissue as a novel adjunctive treatment in hidradenitis suppurativa".
Journal: JAAD case reports
Published: August 08, 2026
Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis.
Journal: Journal of the American Academy of Dermatology
Published: January 14, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis.
Journal: JAMA dermatology
Published: January 07, 2026
IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in Psoriasis.
Journal: International journal of molecular sciences
Published: December 11, 2025
Vaccination of individuals undergoing immunosuppressive therapy
Journal: Ugeskrift for laeger
Published: November 21, 2025
Dermal Fibroblasts, Not Keratinocytes, Dominate IL-17A/TNF-Driven Inflammation.
Journal: Experimental dermatology
Published: November 05, 2025
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.
Journal: JAMA dermatology
Published: October 22, 2025
Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa.
Journal: Frontiers in immunology
Published: September 29, 2025
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort Study.
Journal: Clinical and experimental dermatology
Published: September 15, 2025
Changes in drug survival of adalimumab over time in patients with psoriasis: a nationwide cohort study.
Journal: Clinical and experimental dermatology
Published: September 15, 2025
Exploring associations of single nucleotide polymorphisms in ERAP1 and ERAP2 with susceptibility to multiple immune-mediated inflammatory diseases.
Journal: Human immunology
Published: May 07, 2025
Last Updated: 09/26/2026